DOI: 10.1146/annurev.med.52.1.108 GH Deficiency and Replacement Research Extensive pre-clinical and clinical research using recombinant hGH has characterised the effects of GH deficiency across the lifespan from childhood growth failure to adult-onset GH deficiency with associated body composition, metabolic, and quality-of-life effects establishing the pharmacological profile of HGH 191AA replacement in deficiency models that forms the pre-clinical basis for current GH replacement research
Across all 19 drugs, measured against a standard scale of energy, pain, day-to-day function and mood, no drug produced a change large enough to count as a meaningful improvement at one year not tirzepatide, not semaglutide, not any of the rest
PMID 4682131
Its NSF-certified and physician-formulated to support users navigating reduced intake, food aversions, and digestive changes
we focus on medications with established clinical backing like Wegovy, Oral Wegovy, Zepbound, and Foundayo